Lyman, Gary;
Carrier, Marc;
Ay, Cihan;
Nisio, Marcello;
Hicks, Lisa;
Khorana, Alok;
Leavitt, Andrew;
Lee, Agnes;
Macbeth, Fergus;
Morgan, Rebecca;
Noble, Simon;
Sexton, Elizabeth;
Stenehjem, David;
Wiercoioch, Wojtek;
Kahale, Lara;
Alonso-Coello, Pablo.
Venous thromboembolism (VTE) is a common complication among patients with cancer. Patients with cancer and VTE are at a markedly increased risk for morbidity and mortality. These evidence-based guidelines of the American Society of Hematology (ASH) are intended to support patients, clinicians, and other ...
Macle, L;
Cairns, J;
Leblanc, K;
Tsang, T;
Skanes, A;
Cox, JL;
Healey, JS;
Bell, A;
Pilote, L;
Andrade, JG;
Mitchell, LB;
Atzema, C;
Gladstone, D;
Sharma, M;
Verma, S;
Connolly, S;
Dorian, P;
Parkash, R;
Talajic, M;
Nattel, S;
Verma, A.
The Canadian Cardiovascular Society (CCS) Atrial Fibrillation (AF) Guidelines Committee provides periodic reviews of new data to produce focused updates that address clinically important advances in AF management. This 2016 Focused Update deals with: (1) the management of antithrombotic therapy for AF pa...
Anticoagulantes,
Cardiotónicos,
Inhibidores de Agregación Plaquetaria,
Digoxina,
Magnesio,
Síndrome Coronario Agudo/terapia,
Algoritmos,
Anticoagulantes/uso terapéutico,
Apéndice Atrial/cirugía,
Fibrilación Atrial,
Estimulación Cardíaca Artificial,
Cardiotónicos/efectos adversos,
Ablación por Catéter,
Cardiotónicos/administración & dosificación,
Fibrilación Atrial/terapia,
Fibrilación Atrial/complicaciones,
Hemorragia/inducido químicamente,
Hemorragia/prevención & control,
Magnesio/uso terapéutico,
Intervención Coronaria Percutánea,
Inhibidores de Agregación Plaquetaria/uso terapéutico,
Complicaciones Posoperatorias/prevención & control,
Infarto del Miocardio con Elevación del ST/terapia,
Accidente Cerebrovascular/prevención & control,
Enfermedad de la Arteria Coronaria/complicaciones,
Digoxina/administración & dosificación,
Digoxina/efectos adversos,
Quimioterapia Combinada,
Inhibidores del Factor Xa/uso terapéutico,
Fibrinolíticos/uso terapéutico,
Inhibidores del Factor Xa
Disminuir la heterogeneidad de la atención pre e intrahospitalaria del TCE severo en Colombia para generar una práctica basada en evidencia científica. Establecer criterios para la referencia yel traslado de pacientes adultos con TCE dentro de un sistema de atención en trauma. Promover una eficienci...
Chest; 141 (2,supl), 2012
The Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines differs substantially from the prior versions both in process and in content. In this introduction, we describe some of the differences and the rationale for t...
Guyatt, G. H;
Norris, S. L;
Schulman, S;
Hirsh, J;
Eckman, M. H;
Akl, E. A;
Crowther, M;
Vandvik, P. O;
Eikelboom, J. W;
McDonagh, M. S;
Lewis, S. Z;
Gutterman, D. D;
Cook, D. J;
Schünemann, H. J.
Chest; 141 (2,supl), 2012
BACKGROUND: To develop the Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: ACCP Evidence-Based Clinical Practice Guidelines (AT9), the American College of Chest Physicians (ACCP) assembled a panel of clinical experts, information scientists, decision scientists, and systematic review and gui...
Since publication of the seventh American College of Chest Physicians (ACCP) supplement on antithrombotic and thrombolytic therapy, the results of clinical trials have provided important new information on the management of thromboembolic disorders, and the science of developing recommendations has advan...
